Women’s health company Organon has received clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for technological updates to the JADA System, intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The product updates include a new kit configuration with updated packaging, as well as a streamlined design to…
![](https://femtechinsider.com/wp-content/uploads/2021/10/organon-jada.png)